Characteristics of TMS studies (adapted from Yamada et al. [11]).
Abstract
Patients with schizophrenia suffer from impairments of social cognition that represent mental operations underlying real-world functioning. Pharmacological approaches have been attempted to overcome social cognitive disturbances of schizophrenia, but only yielded insufficient effects. As an alternative approach, some types of neuromodulations, particularly non-invasive brain stimulation, e.g., transcranial direct current stimulation (tDCS), have been drawing attention. While previous studies have performed anodal tDCS at the frontal brain regions, we hypothesized anodal stimulation at the temporal region would improve social cognitive function on the basis of the neural circuit governing it. Thus, our data indicate multisession tDCS delivered to the left superior temporal sulcus improves social cognition in patients with schizophrenia. In the present chapter, we overview studies of tDCS on social cognition and discuss optimal brain regions to be targeted for ameliorating symptoms and cognitive disturbances of schizophrenia.
Keywords
- neuromodulation
- transcranial direct current stimulation (tDCS)
- schizophrenia
- social cognition
- social function
1. Introduction
Schizophrenia is one of the most severe psychiatric diseases that affects approximately 0.75% of the world’s population [1]. It is characterized by varying degrees of positive (e.g., auditory and/or visual hallucinations, delusions, psychomotor agitation, and paranoia), negative (e.g., apathy, deficits in motivation, social withdrawal, and reward-related functions), and cognitive symptoms (e.g., neurocognition and social cognition). Typically, the onset of schizophrenia is between the end of adolescence and the beginning of early adulthood. The disease has a chronic course with a myriad of psychotic episodes that generally lead to deterioration in real-world functional outcomes [2].
Cognitive impairment is a fundamental symptom of schizophrenia, with mild deficits appearing before the onset of psychosis, followed by an acute decline around the first episode psychosis (FEP), and maintains to the chronic stages [2]. Specifically, neurocognition, e.g., working memory, verbal/visual learning and memory, attention, speed of processing, reasoning, and problem-solving, represents cognitive domains that are impaired in most patients. Similarly, impairments of social cognition have been considered as a target for the improvement of functional outcomes [2]. Social cognition is defined as mental operations underlying social behavior and includes domains of the theory of mind (ToM), emotion processing, social perception, and attributional bias/style (see Figure 1) [4]. Moreover, social cognition, especially ToM, is associated with social functioning [5], similar to the case for neurocognition [6]. Therefore, these areas of cognitive function have been considered a key target for interventions to improve the functionality of people with psychotic conditions.
Several pharmacological approaches have been tried to enhance social cognition in patients with schizophrenia [7]. In particular, intranasal oxytocin [8], psychostimulants (e.g., modafinil) [2], antipsychotic drugs (e.g., risperidone, olanzapine) [9], and acetylcholinesterase inhibitors [10] have been tested as candidate compounds. Of these, intranasal oxytocin and some atypical antipsychotic drugs may improve ToM [8] and emotion processing [9], respectively, while anti-dementia drugs (e.g., donepezil, galantamine, rivastigmine, and memantine) are less effective. Therefore, further research, including new therapeutic intervention techniques, is desperately needed to overcome social cognitive dysfunction.
2. Non-invasive brain stimulation for social cognitive impairments
As alternative approaches to the alleviation of social cognitive impairments, some types of neuromodulations, particularly non-invasive brain stimulation (NIBS), e.g., transcranial magnetic stimulation (TMS) or transcranial electrical stimulation (tES), have been attempted [11]. NIBS has the potential to improve functional outcomes by directly stimulating social brain areas, which is likely to facilitate or modulate neurotransmissions in the central nervous system [12, 13]. In particular, TMS has the advantage of accurately stimulating deeper cortical structures that are difficult to reach with tES. On the other hand, tES techniques are advantageous in terms of cost, portability, and safety [11]. Moreover, multi-session tES is thought to promote neuroplastic changes in cortical circuits by inducing long-term potentiation (LTP), which enhances the efficiency of information processing [12, 13]. Therefore, tES may improve functional outcomes by ameliorating social cognitive impairments in patients with schizophrenia.
Previous studies with TMS or tES, with the dorsolateral prefrontal cortex (DLPFC), as the stimulation site, have shown limited effects on social cognition, especially ToM [11]. For example, a single-session continuous theta burst stimulation, a type of TMS, over the right inferior parietal lobe (IPL) enhanced social perception [14], while multi-session high-frequency repetitive TMS over the left DLPFC improved emotional recognition (Table 1) [15]. On the other hand, single-session transcranial direct current stimulation (tDCS) delivered to the left frontal pole improved emotion recognition [16], whereas stimulation of the left DLPFC did not show such effects (Table 2) [17]. Overall, stimulations of frontal brain regions are advantageous to improve emotion recognition and social perception, but not ToM. To enhance the latter domain of social cognition, other stimulation sites need to be investigated.
Study | Walther et al. [14] | Wölwer et al. [15] | |
---|---|---|---|
Diagnosis | Schizophrenia | Schizophrenia | |
Sample size (active/sham) | 20/20 | 18/14 | |
Location (stimulation) | Left IFG (iTBS) | Right IPL (cTBS) | Left DLPFC |
Duration (days) | 1 | 10 | |
Evaluation | online | within 12 hours after stimulation | |
Outcomes | TULIA | Pictures of Facial Affect | |
Results | No significant effect | Significant effects on social perception | Significant effects in emotion recognition |
Study | Rassovsky et al., 2018 [17] | Rassovsky et al., 2015 [16] |
---|---|---|
Diagnosis | Schizophrenia | Schizophrenia |
Sample size (active/sham) | 37/37 | 12/12 |
Montage (Anode/cathode) | F3/Fp2 | Fp1/Fp2 |
No. of sessions | 2 | 1 |
Evaluation | online | online |
Outcomes | TASIT, EAT, EIT, MSCEIT | TASIT, PONS, FEIT, MSCEIT |
Results | No significant effect | Significant effects in emotion recognition |
The neural substrates governing social cognition include the superior temporal sulcus (STS), amygdala, medial prefrontal cortex, and orbitofrontal cortex. Specifically, functional connectivity among these brain regions is weakened in patients with schizophrenia [18, 19, 20]. Among them, the amygdala is involved in emotion recognition, while the prefrontal cortex is responsible for generating ToM. On the other hand, the STS is considered to play a role in both domains of social cognition (Table 3) [18, 19]. Therefore, we hypothesized that anodal stimulation over the left STS would be advantageous for treating social cognition disturbances [18, 19].
Domains of social cognition | Neural basis |
---|---|
Theory of mind (ToM) | Superior temporal sulcus (STS), medial prefrontal cortex (mPFC), middle temporal gyrus, etc. |
Emotion recognition/processing | Amygdala, superior temporal sulcus (STS), medial prefrontal cortex (mPFC), inferior occipital gyrus, etc. |
Attributional bias/style | Orbitofrontal cortex, insular cortex, striatum, amygdala, superior temporal sulcus (STS), etc. |
3. tDCS over the left temporal brain region improves social cognition
We conducted an open-label, single-arm trial designed to evaluate the effects and safety of multi-session tDCS on the left STS [18, 21]. The intervention was performed by a 1 × 1 transcranial direct current low-intensity stimulator (Model 1300 A; Soterix Medical Inc., New York, NY, USA). For the tDCS montage, the anode electrode was placed for the left STS and the cathode for the contralateral supraorbital region, which corresponded to the T3 and FP2 regions (Figure 2) in the International 10–20 electroencephalography system. We applied 10 sessions of direct current of 2 mA for 20 min on 5 consecutive days (twice per day, with an interval of 30 min). Clinical data were collected at baseline and 1 month after the final stimulus (Table 4). As a result, significant improvements were found on the tests of ToM, i.e., Social Cognition Screening Questionnaire (SCSQ) (
Study period | |||||
---|---|---|---|---|---|
Baseline | Intervention | Follow-up | |||
Time point | Within 2 weeks before the start of intervention | Day 1 | Days 2–4 | Day 5 | 1 month after the end of the last stimulation |
Eligibility screen | X | ||||
Informed consent | X | ||||
Sociodemographic characteristics | X | ||||
tDCS (twice/day) | X | X | X | ||
SCSQ | X | X | |||
Hinting Task | X | X | |||
FEST | X | X | |||
Adverse events | X | X | X | X | X |
Prescribed drugs | X | X | X | X | X |
Contrary to the results of our observations, previous studies report the absence of sufficient improvement of social cognitive functioning, including ToM, during or immediately after one or two sessions of tDCS in patients with schizophrenia (Table 2). By contrast, the effects in our study became evident 1 month after the last tDCS. The specific effects of multi-session tDCS that are associated with the prolonged (i.e., 1-month) change of social cognition may be mediated through several mechanisms, including the LTP, a continuous enhancement of signal transduction between neurons, and related neural events [12, 13]. As social cognition is considered to be linked to functional outcomes [5], multi-session, rather than single-session tDCS may provide benefits for functional recovery in patients with schizophrenia.
The current results, with tDCS as an interventional tool, may facilitate an understanding of the neural basis for social cognitive dysfunction. The neural circuity governing social cognition consists of the orbitofrontal cortex, medial prefrontal cortex, superior temporal sulcus/gyrus, and amygdala, in which the amygdala is considered as a hub [18, 19, 20]. Specifically, the amygdala interconnects with both temporal lobes, e.g., STS, and frontal lobes, e.g., orbitofrontal and medial prefrontal cortex (Figure 4) [20]. Also, the amygdala receives various sensory stimuli, and projects them to a wide range of cortical areas, most notably the STS and orbitofrontal cortex [20]. In patients with schizophrenia, functional connectivity among these brain regions is weakened [18, 19, 20]. Thus, pro-cognitive effects of tDCS may be associated with modification of functional connectivity, possibly through modulation of neurotransmissions [12, 13].
A strength of tDCS is its simplicity, which allows implementation in clinical settings without requiring expensive equipment, e.g., magnetic resonance imaging (MRI) machines. Such feasibility of tDCS is advantageous in, e.g., being built-in the telemedicine system.
4. Limitations
First, the small sample size of the present study may raise caution in assuming that the results can be generalized to the population. Second, as the study design is not randomized or blinded, the possibility of a placebo effect may not be completely ruled out. Third, although tDCS allows the selection of stimulation sites according to the targeted symptoms, it is difficult to fully ascertain if the electrical stimulation effectively modulates the targeted functional connectivity.
5. Conclusions
tDCS delivered to the left STS may produce benefits for some domains of social cognition, especially ToM, in patients with schizophrenia. Further investigations are warranted to determine if the type of functional outcome (e.g., daily-living activities, social function) would depend on the region of the brain stimulated by tDCS. These efforts may provide an effective therapeutic strategy to facilitate personal recovery for these patients.
Acknowledgments
We would like to thank Dr. Zui Narita and Mr. Kazuki Sueyoshi at the National Center of Neurology and Psychiatry for their valuable help.
Funding
The studies discussed in this chapter were partly supported by the Japan Society for the Promotion of Science KAKENHI Grant No.20 K16635 to YY, as well as JSPS KAKENHI Grant No. 20H03610, the Japan Health Research Promotion Bureau Grants (2020-B-08, 2021-B-01), Intramural Research Grant (2-3, 3-1) for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry to TS.
Ethics statement
The study was performed according to the Declaration of Helsinki and followed the Clinical Trials Act in Japan. The protocol was presented for approval by the National Center of Neurology and Psychiatry Clinical Research Review Board (CRB3180006).
References
- 1.
Moreno-Küstner B, Martín C, Pastor L. Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. PLoS One. 2018; 13 (4):e0195687 - 2.
Yamada Y, Inagawa T, Sueyoshi K, Sugawara N, Ueda N, Omachi Y, et al. Social cognition deficits as a target of early intervention for psychoses: A systematic review. Frontiers in Psychiatry. 2019; 10 :333 - 3.
Pinkham AE, Penn DL, Green MF, Buck B, Healey K, Harvey PD. The social cognition psychometric evaluation study: Results of the expert survey and RAND panel. Schizophrenia Bulletin. 2014; 40 (4):813-823 - 4.
Couture SM, Penn DL, Roberts DL. The functional significance of social cognition in schizophrenia: A review. Schizophrenia Bulletin. 2006; 32 (Suppl 1):S44-S63 - 5.
Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis. Neuroscience and Biobehavioral Reviews. 2011; 35 (3):573-588 - 6.
Sumiyoshi T, Nishida K, Niimura H, Toyomaki A, Morimoto T, Tani M, et al. Cognitive insight and functional outcome in schizophrenia; a multi-center collaborative study with the specific level of functioning scale-Japanese version. Schizophraphy Research Cognition. 2016; 6 :9-14 - 7.
Yamada Y, Okubo R, Tachimori H, Uchino T, Kubota R, Okano H, et al. Pharmacological interventions for social cognitive impairments in schizophrenia: A protocol for a systematic review and network meta-analysis. Frontiers in Psychology. 2022; 13 :878829 - 8.
Bürkner PC, Williams DR, Simmons TC, Woolley JD. Intranasal oxytocin may improve high-level social cognition in schizophrenia, but not social cognition or Neurocognition in general: A multilevel Bayesian Meta-analysis. Schizophrenia Bulletin. 2017; 43 (6):1291-1303 - 9.
Gabay AS, Kempton MJ, Mehta MA. Facial affect processing deficits in schizophrenia: A meta-analysis of antipsychotic treatment effects. Journal of Psychopharmacology. 2015; 29 (2):224-229 - 10.
Kishi T, Ikuta T, Oya K, Matsunaga S, Matsuda Y, Iwata N. Anti-dementia drugs for psychopathology and cognitive impairment in schizophrenia: A systematic review and Meta-analysis. The International Journal of Neuropsychopharmacology. 2018; 21 (8):748-757 - 11.
Yamada Y, Inagawa T, Hirabayashi N, Sumiyoshi T. Emotion recognition deficits in psychiatric disorders as a target of non-invasive Neuromodulation: A systematic review. Clinical EEG and Neuroscience. 2022; 53 (6):506-512 - 12.
Yamada Y, Sumiyoshi T. Neurobiological mechanisms of transcranial direct current stimulation for psychiatric disorders; neurophysiological, chemical, and anatomical considerations. Frontiers in Human Neuroscience. 2021; 15 :631838 - 13.
Yamada Y, Sumiyoshi T. Preclinical evidence for the mechanisms of transcranial direct current stimulation in the treatment of psychiatric disorders: A systematic review. Clinical EEG Neuroscience. 2021; 13 :15500594211066151 - 14.
Walther S, Kunz M, Müller M, Zürcher C, Vladimirova I, Bachofner H, et al. Single session transcranial magnetic stimulation ameliorates hand gesture deficits in schizophrenia. Schizophrenia Bulletin. 2020; 46 (2):286-293 - 15.
Wölwer W, Lowe A, Brinkmeyer J, Streit M, Habakuck M, Agelink MW, et al. Repetitive transcranial magnetic stimulation (rTMS) improves facial affect recognition in schizophrenia. Brain Stimulation. 2014; 7 (4):559-563 - 16.
Rassovsky Y, Dunn W, Wynn J, Wu AD, Iacoboni M, Hellemann G, et al. The effect of transcranial direct current stimulation on social cognition in schizophrenia: A preliminary study. Schizophrenia Research. 2015; 165 (2-3):171-174 - 17.
Rassovsky Y, Dunn W, Wynn JK, Wu AD, Iacoboni M, Hellemann G, et al. Single transcranial direct current stimulation in schizophrenia: Randomized, cross-over study of neurocognition, social cognition, ERPs, and side effects. PLoS One. 2018; 13 (5):e0197023 - 18.
Yamada Y, Inagawa T, Yokoi Y, Shirama A, Sueyoshi K, Wada A, et al. Efficacy and safety of multi-session transcranial direct current stimulation on social cognition in schizophrenia: A study protocol for an open-label, single-arm trial. Journal of Persian Medicine. 2021; 11 (4):317 - 19.
Yamada Y, Sumiyoshi T. Transcranial direct current stimulation and social cognition impairments of Schizophrenia; current knowledge and future Perspectives. Horizons in Neuroscience Research. 2022; 46 . New York: Nova Science Publishers:143-170 - 20.
Yamada Y, Matsumoto M, Iijima K, Sumiyoshi T. Specificity and continuity of schizophrenia and bipolar disorder: Relation to biomarkers. Current Pharmaceutical Design. 2020; 26 (2):191-200 - 21.
Yamada Y, Sueyoshi K, Yokoi Y, Inagawa T, Hirabayashi N, Oi H, et al. Transcranial direct current stimulation on the left superior temporal sulcus improves social cognition in schizophrenia: An open-label study. Frontiers in Psychiatry. 2022; 13 :862814